Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:06609's Gross Margin % is ranked better than 81.59% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 52.26
vs HKSE:06609: 70.92
Shanghai HeartCare Medical Technology had a gross margin of 73.14% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Shanghai HeartCare Medical Technology (HKSE:06609) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shanghai HeartCare Medical Technology had a gross margin of 73.14% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shanghai HeartCare Medical Technology Gross Margin % Related Terms
Shanghai HeartCare Medical Technology Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai HeartCare Medical Technology Gross Margin % Chart
HKSE:06609 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai HeartCare Medical Technology Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai HeartCare Medical Technology's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shanghai HeartCare Medical Technology (HKSE:06609) has a Gross Margin % of 73.14% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai HeartCare Medical Technology and its competitors. This is 10% above median its historical median of 66.66. Over the past decade, Shanghai HeartCare Medical Technology's Gross Margin % has ranged from 48.67 to 70.92. According to the industry distribution chart, Shanghai HeartCare Medical Technology ranks #148 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 18.4%.
Is Shanghai HeartCare Medical Technology's Gross Margin % too high?
Shanghai HeartCare Medical Technology's current Gross Margin % of 73.14% is 10% above median its 10-year median of 66.66. Over the past 10 years, this metric has ranged from a low of 48.67 to a high of 70.92. The Medical Devices & Instruments industry median Gross Margin % is 52.26. Shanghai HeartCare Medical Technology's value of 73.14% is 40% above this industry median. Based on the distribution chart, Shanghai HeartCare Medical Technology ranks #148 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai HeartCare Medical Technology has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai HeartCare Medical Technology's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai HeartCare Medical Technology ranks #148 out of 804 companies for Gross Margin %. This places Shanghai HeartCare Medical Technology in the top 18% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.26. Shanghai HeartCare Medical Technology's value of 73.14% is 40% above this benchmark. Historically, Shanghai HeartCare Medical Technology's own Gross Margin % has ranged from 48.67 to 70.92 over the past decade. While the company's 10-year median is 66.66 vs. the industry median of 52.26, Shanghai HeartCare Medical Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.26, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai HeartCare Medical Technology's current Gross Margin % of 73.14% is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai HeartCare Medical Technology and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai HeartCare Medical Technology's current Gross Margin % is 73.14%, which is 10% above median its own 10-year median of 66.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai HeartCare Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology (HKSE:06609) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$54.80, compared to a current price of HK$48.24 — trading 12% below its estimated fair value. The current Gross Margin % is 73.14%, which is 10% above median its 10-year median of 66.66 and 40% above the Medical Devices & Instruments industry median of 52.26. Shanghai HeartCare Medical Technology's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shanghai HeartCare Medical Technology (HKSE:06609), the current Gross Margin % is 73.14% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai HeartCare Medical Technology (HKSE:06609) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology stock appears to be undervalued.
The current stock price of HK$48.24 is trading 12% below its estimated GF Value™ of HK$54.80.
GuruFocus considers Shanghai HeartCare Medical Technology to be Modestly Undervalued.
Key valuation signals for HKSE:06609:
Gross Margin %: 73.14% (10% above median its 10-year median of 66.66)
GF Value™: HK$54.80 vs. price of HK$48.24 (12% below fair value)
Industry Position: 40% above the Medical Devices & Instruments median (#148 of 804)
No single metric tells the full story. See the HKSE:06609 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
78GF Score
Get the complete analysis for HKSE:06609
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06609 has been successfully added to your 
